COVID-19 Committee

1. Covid-19: Vaccination programme: The Committee will take evidence from—
Steve Hoare, Director of Quality, Regulatory Science & Safety, Association of the British Pharmaceutical Industry (ABPI);
Professor Andrew Pollard, Professor of Paediatric Infection and Immunity, University of Oxford, Oxford Vaccine Group;
Professor Wei Shen Lim, Chair of COVID-19 Immunisation, Joint Committee on Vaccination and Immunisation (JCVI);
Dr Christian Schneider, Chief Scientific Officer, National Institute for Biological Standards and Control, Medicines & Healthcare products Regulatory Agency (MHRA).

2. Ministerial statement: Covid-19; and Subordinate legislation: The Committee will take evidence on the latest Ministerial Statement on Covid-19; the Health Protection (Coronavirus) (Restrictions and Requirements) (Local Levels) Amendment (No.5) Regulations 2020 (SSI 2020/400); the Health Protection (Coronavirus) (Restrictions and Requirements) (Local Levels) Amendment (No.6) Regulations 2020 (SSI 2020/415) and the Health Protection (Coronavirus) (Restrictions and Requirements) (Local Levels) Amendment (No.7) Regulations 2020 (SSI 2020/427) from—
Michael Russell, Cabinet Secretary for the Constitution, Europe and External Affairs, and Professor Jason Leitch, National Clinical Director, Scottish Government.

3. Subordinate legislation: Michael Russell, Cabinet Secretary for the Constitution, Europe and External Affairs, to move—
S5M-25354? That the Covid-19 Committee recommends that the Health Protection (Coronavirus) (Restrictions and Requirements) (Local Levels) (Scotland) Amendment (No. 5) Regulations 2020 (SSI 2020/400) be approved. S5M-23603? That the COVID-19 Committee recommends that the Health Protection (Coronavirus) (Restrictions and Requirements) (Local Levels) (Scotland) Amendment (No. 6) Regulations 2020 (SSI 2020/415) be approved. S5M-23683? That the COVID-19 Committee recommends that the Health Protection (Coronavirus) (Restrictions and Requirements) (Local Levels) (Scotland) Amendment (No. 7) Regulations 2020 (SSI 2020/427) be approved.